メタドンからブプレノルフィンへの移行への段階的なアプローチ 野外患者でのがん関連の痛み:臨床的に明らかな離脱症状のない新しいオピオイドの回転
Sushma Shivananda1, Pushpa V H2, Tayyaba Irshad1
1Department of Palliative Medicine, University of Illinois College of Medicine Peoria, Peoria, Illinois, USA.
Journal of pain & palliative care pharmacotherapy
|September 3, 2025
まとめ
メタドンからブプレノルフィンの治療に 成功した症例報告です マイクロインダクション法で 痛みの管理と 患者の機能が改善されました
科学分野:
- 腫瘍学
- 痛みの管理
- 薬理学について
背景:
- 長期メタドン治療は がんに関連する痛みに対して一般的です
- メタドンからブプレノルフィンへの移行は 難しいかもしれません
- オピオイド治療の診療は慎重に検討する必要があります.
研究 の 目的:
- メタドンから 舌下ブプレノルフィンの 治療に成功しました
- この移行のためのマイクロ誘導プロトコルの有効性を評価する.
- 痛みのコントロールと副作用を含む患者のアウトカムを評価する.
主な方法:
- 外科ではマイクロインダクションプロトコルを使用した.
- 低用量のブプレノルフィンをメタドンと併用して投与.
- メタドンを止めた後,徐々に言語下ブプレノルフィンを投与する.
主要な成果:
- メタドンからブプレノルフィンの 順調な変換を達成した
- 臨床的に有意な離脱症状は観察されなかった.
- 痛みのコントロールが改善され,副作用が軽減され,機能状態が改善されました.
結論:
- メタドンからブプレノルフィンの段階的な移行は,がんの痛みに対する安全で効果的な門診戦略です.
- マイクロインダクションプロトコルは オピオイドスイッチングの有効なアプローチです
- オピオイドへの移行のための精密医療に関するさらなる研究が必要である.
関連する概念動画
Opioid Analgesics: Synthetic and Semisynthetic Opioids
421
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
421
Analgesia and Pain Management
788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
Opioid Analgesics: Morphine and Other Natural Cogeners
361
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
361
Phase II Reactions: Methylation Reactions
339
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
339
Drug Administration and Therapy Phases: Overview
738
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
738
Opioid Receptors: Overview
1.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.8K


